Bringing biomarkers to clinical practice in metastatic colorectal cancer : primary tumor location, methylation and liquid biopsies
Source
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2024,242 p.
NPY methylated ctDNA is a promising biomarker for treatment response monitoring in metastatic colorectal cancer
Source
Clinical cancer research - ISSN 1557-3265-29:9 (2023) p. 1741-1750
Epigenome-wide methylation analysis of colorectal carcinoma, adenoma and normal tissue reveals novel biomarkers addressing unmet clinical needs
Source
Clinical epigenetics - ISSN 1868-7075-15:1 (2023) p. 1-14
New developments in treating RAS-mutated metastatic colorectal cancer
Source
Current treatment options in oncology - ISSN 1527-2729-24:8 (2023) p. 965-987
A Belgian population-based study reveals subgroups of right-sided colorectal cancer with a better prognosis compared to left-sided cancer
Source
The oncologist - ISSN 1083-7159-28:6 (2023) p. e331-e340